Emily J. Gallagher - Concepedia

Author

Emily J. Gallagher

Icahn School of Medicine at Mount Sinai ORCID

Also Known As

A. Francini, Aloke Finn, Alyssa Civil, Daniel Fierer, Derek LeRoith, E J Gallagher, E. Gallagher, E. J. Gallagher, E.J. Gallagher, Elaine Gallagher

224

Publications

8.9K

Citations

H-Index

104

Concepts

All Affiliations

Icahn School of Medicine at Mount Sinai Harvard University Brigham and Women's Hospital Massachusetts General Hospital New York University

About

Emily J. Gallagher is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, immunology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	27	1.7K
2	Health Sciences	7	7	139
3	Public Health	4	4	95
4	Engineering	3	3	53
5	Biochemistry	1	1	28

Emily J. Gallagher

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection Tanayott Thaweethai, Sarah E. Jolley, Elizabeth W. Karlson, JAMA	2023	792
Dietary Intake Regulates the Circulating Inflammatory Monocyte Pool Stefan Jordan, Navpreet Tung, María Casanova-Acebes, Cell InflammationAutoimmune DiseaseImmune RegulationImmunologyChronic Inflammation	2019	425
Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States Jennifer E. Flythe, Magdalene M. Assimon, Matthew J. Tugman, American Journal of Kidney Diseases HemodialysisIntensive Care UnitsMedicineKidney FailureAcute Care	2020	231
Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia Emily J. Gallagher, Zara Zelenko, Brian A. Neel, Oncogene Breast OncologyPathologyMouse ModelsHyperlipidemiaBreast Cancer	2017	222
Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model Nyosha Alikhani, R D Ferguson, Ruslan Novosyadlyy, Oncogene Mammary Gland DevelopmentHyperlipidemic Mouse ModelMedicineCancer GrowthPathology	2012	145
Survival of Patients with Stage IV Lung Cancer with Diabetes Treated with Metformin Jenny J. Lin, Emily J. Gallagher, Keith Sigel, American Journal of Respiratory and Critical Care Medicine	2014	136
The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer Nitai C. Hait, Dorit Avni, Akimitsu Yamada, Oncogenesis	2015	100
Inhibiting PI3K reduces mammary tumor growth and induces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemia Emily J. Gallagher, Yvonne Fierz, A Vijayakumar, Oncogene Insulin ResistanceTumor BiologyMedicinePharmacologyMouse Model	2011	80
Higher levels of heat shock proteins in longer-lived mammals and birds Kurtis D. Salway, Emily J. Gallagher, Melissa M. Page, Mechanisms of Ageing and Development BiologyAnimal PhysiologyHigher LevelsProtein FoldingHeat Shock Proteins	2011	73
Insulin Receptor Phosphorylation by Endogenous Insulin or the Insulin Analog AspB10 Promotes Mammary Tumor Growth Independent of the IGF-I Receptor Emily J. Gallagher, Nyosha Alikhani, Aviva Tobin‐Hess, Diabetes Breast OncologyImmunologyInsulin Receptor PhosphorylationIgf-i ReceptorInsulin Signaling	2013	64

Page 1